These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6830691)

  • 1. The effects of regional factors on the growth rate and the differentiation of mouse teratocarcinoma.
    Oosterhuis JW; Bagasra O; Kushner H; Fox N; Damjanov I
    Br J Cancer; 1983 Mar; 47(3):407-11. PubMed ID: 6830691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
    Gordeeva OF; Nikonova TM
    Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.
    Martin GR
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7634-8. PubMed ID: 6950406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].
    Jakob H; Boon T; Gaillard J; Nicolas J; Jacob F
    Ann Microbiol (Paris); 1973 Oct; 124(3):269-82. PubMed ID: 4599372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the growth and differentiation of teratocarcinoma OC15S1 in syngeneic and allogeneic mice].
    Dyban PA
    Biull Eksp Biol Med; 1984 Jan; 97(1):71-2. PubMed ID: 6692027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-forming cell line derived from embryonal carcinoma cells.
    Nicolas JF; Gaillard J; Jakob H; Jacob F
    Nature; 1980 Aug; 286(5774):716-8. PubMed ID: 6931966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and differentiation of an embryonal carcinoma cell line (C145b).
    Papaioannou VE; Evans EP; Gardner RL; Graham CF
    J Embryol Exp Morphol; 1979 Dec; 54():277-95. PubMed ID: 528871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.
    Atsumi T; Shirayoshi Y; Takeichi M; Okada TS
    Differentiation; 1982; 23(1):83-6. PubMed ID: 7152170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse.
    Levy JA; White AC; McGrath CM
    Br J Cancer; 1982 Mar; 45(3):375-83. PubMed ID: 7073933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotent teratocarcinoma-thymus somatic cell hybrids.
    Miller RA; Ruddle FH
    Cell; 1976 Sep; 9(1):45-55. PubMed ID: 61820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratocarcinoma: neoplastic lessons about normal embryogenesis.
    Damjanov I
    Int J Dev Biol; 1993 Mar; 37(1):39-46. PubMed ID: 8507568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
    Litwack G; Croce CM
    J Cell Physiol; 1979 Oct; 101(1):1-8. PubMed ID: 44296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein in tumours derived from cystic and simple embryoid bodies.
    Monzó M; de Anta JM; Peris B; Ruano D
    Arch Ital Anat Embriol; 1991; 96(2):113-20. PubMed ID: 1725250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age and sex of host mice on growth and differentiation of teratocarcinoma OTT6050.
    Kubota K; Kubota R; Takeda S; Matsuzawa T
    Exp Gerontol; 1981; 16(5):371-84. PubMed ID: 7318969
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth and differentiation of pluripotent embryonal carcinoma cells in the Snell dwarf mouse.
    van der Kamp AW; van Buul-Offers SC; Roza-de Jongh EJ; Feijlbrief M; Branger J; van Rongen E
    Br J Cancer; 1984 Oct; 50(4):479-82. PubMed ID: 6534385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
    Lehtonen E; Laasonen A; Tienari J
    Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen on the growth of mouse teratocarcinoma OTT6050 in vivo.
    Kubota K; Kubota R; Matsuzawa T
    Oncodev Biol Med; 1983; 4(5):309-17. PubMed ID: 6856482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and differentiation of teratocarcinoma OTT6050 affected by host hormonal changes in old mice.
    Kubota K; Kubota R; Matsuzawa T
    Tohoku J Exp Med; 1987 Mar; 151(3):253-9. PubMed ID: 3590172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.